Healthcare Services

Increasing Adoption Of Rising Incidence Of Bone-Related Diseases To Drive Growth In The Bone and Mineral Diagnostic Testing Market Is Influencing The Bone and Mineral Diagnostic Testing Market

May 26, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Market Value Trend Is Expected For The Bone and Mineral Diagnostic Testing Market From 2026 To 2030?

The bone cancer treatment market has shown significant expansion in recent years. It is anticipated to grow from $1.37 billion in 2025 to $1.45 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 5.6%. This historical growth can be linked to several factors, such as the increasing incidence of bone-related cancers, the expansion of oncology treatment centers, the availability of chemotherapy and radiation therapies, improved cancer diagnostic capabilities, and growing clinical research activity.

The bone cancer treatment market is projected to experience robust expansion in the coming years. This market is anticipated to reach $1.83 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.1%. Several factors are expected to drive this growth during the forecast period, including heightened investments in targeted therapies and immunotherapies, a greater embrace of personalized cancer treatment approaches, the development of sophisticated surgical oncology methods, an increased emphasis on research into rare cancers, and improved availability of specialized oncology services. Key trends anticipated for the forecast period involve a wider uptake of targeted bone cancer therapies, an increase in multimodal treatment strategies, the broader incorporation of precision oncology solutions, advancements in radiation and surgical techniques, and a sharpened focus on early detection coupled with individualized patient care.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10731&type=smp

What Primary Factors Are Fueling The Expansion Of The Bone and Mineral Diagnostic Testing Market?

The rising incidence of bone cancer is anticipated to propel the expansion of the bone cancer treatment market. Bone cancer refers to malignant tumors that develop within bone tissue, resulting from the uncontrolled division and growth of bone cells, which form a mass or tumor. Treatments for this condition are formulated to provide patients with various benefits, including surgery, limb preservation, pain alleviation, enhanced quality of life, and effective tumor management. For example, in February 2023, reports from the American Society of Clinical Oncology (ASCO), a US-based professional organization for physicians, projected that approximately 3,970 new cases of primary bone sarcoma (comprising 2,160 men and 1,810 women) would be diagnosed in the US in 2023, an increase from 400 cases in 201 among individuals aged 15 to 19. Therefore, the growing prevalence of bone cancer is a significant factor driving the bone cancer treatment market.

What Key Segment Areas Are Included In The Bone and Mineral Diagnostic Testing Market Assessment?

The bone and mineral diagnostic testing market covered in this report is segmented –

1) By Product: Assays Or Consumables, Instruments

2) By Test Type: Enzyme-Linked Immunosorbent Assay (ELISA), Clinical Laboratory Improvement Amendments (CLIA), Other Test Types

3) By Application: Vitamin D Testing, Bone Metabolism

Subsegments:

1) By Assays Or Consumables: Bone Turnover Markers Assays, Vitamin D Assays, Calcium And Phosphate Assays, Sample Collection Kits, Reagents And Standards

2) By Instruments: Bone Densitometers, X-Ray Machines, Ultrasound Devices

Which Trends Are Influencing The Expansion Of The Bone and Mineral Diagnostic Testing Market?

Leading companies operating in the bone cancer treatment market are concentrating on introducing next-generation drugs, including prescription medications, to gain a competitive advantage. A prescription medicine is a pharmaceutical drug that can only be legally obtained through a written order from a qualified healthcare professional, such as a doctor or dentist. As an illustration, in September 2023, GSK PLC, a UK-based pharmaceutical and biotechnology firm, launched Ojjaara (Momelotinib). Ojjaara (Momelotinib) is a prescription medicine utilized to treat adults suffering from certain types of myelofibrosis (MF), a rare form of bone marrow cancer that disrupts the body’s normal production of blood cells. This provides a new and effective treatment option for patients experiencing bone cancer and anemia.

Who Are The Leading Firms Participating In The Bone and Mineral Diagnostic Testing Market?

Major companies operating in the bone and mineral diagnostic testing market are Abbott Laboratories, bioMérieux SA, DiaSorin S.p.A., QuidelOrtho Corporation, Siemens Healthineers AG, F. Hoffmann-La Roche AG, GE HealthCare Technologies Inc., Hologic Inc., Swissray International Inc., Osteosys Co. Ltd., Diagnostic Medical System SA, Epitope Diagnostics Inc., Beckman Coulter Inc., Bio Rad Laboratories Inc., Calbiotech Inc., Roche Diagnostics India Pvt. Ltd., Ortho-Clinical Diagnostics, Enzo Life Sciences Inc., Thermo Fisher Scientific Inc., Sysmex Corporation, EKF Diagnostics, Esaote SpA, Hitachi Ltd., Koninklijke Philips N.V., Mindray Medical International Limited, PerkinElmer Inc., Shimadzu Corporation, Toshiba Medical Systems Corporation, Beammed Ltd., Medonica Co. Ltd.

Access The Complete Bone and Mineral Diagnostic Testing Market Report:

https://www.thebusinessresearchcompany.com/report/bone-and-mineral-diagnostic-testing-global-market-report

Which Region Commands The Largest Share Of The Bone and Mineral Diagnostic Testing Market?

North America was the largest region in the bone and mineral diagnostic testing market in 2025. The regions covered in the bone and mineral diagnostic testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Bone and Mineral Diagnostic Testing Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=10731&type=smp

Browse Through More Reports Similar to the Global Bone and Mineral Diagnostic Testing Market 2026, By The Business Research Company

Mineral And Bone Disorder Treatment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/mineral-and-bone-disorder-treatment-global-market-report

Bone Densitometer Market 2026

https://www.thebusinessresearchcompany.com/report/bone-densitometer-market

Osteoporosis Drugs Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/osteoporosis-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795